|
|
||||||||
American Journal of Clinical Nutrition, Vol 36, 79-86, Copyright © 1982 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
MC Gupta and JJ Urrutia
One hundred fifty-nine children aged 24 to 61 months with 60% ascariasis prevalence and 21.5% giardiasis prevalence in rural Guatemala were studied prospectively for 1 yr. They were divided into four groups comparable for age, sex, socioeconomic status, and past growth experience as judged by slopes of height and weight on age. Each group was randomly assigned to the following 2-monthly treatment regimens: group I, placebo, group II, piperazine, group III, metronidazole; group IV, piperazine and metronidazole. Height and weight were measured every 3 months and stools were examined for parasites every 4 months. Piperazine administration decreased the prevalence of ascariasis to 33.8% at the end of the study but growth remained unaltered. Metronidazole administration decreased the prevalence of giardiasis to 2.5% at the end of the study and was accompanied by increased growth as judged by delta weight, delta % weight for age, slope of weight on age, delta height, delta % height for age and slope of height on age. It is suggested that failure of antiascaris treatment to enhance growth in this study may be because of 1) absence of severe malnutrition in the subjects, 2) adequacy of dietary protein, 3) possible low worm load, and 4) failure to eradicate ascariasis. The findings suggest that giardiasis is associated with reduced growth in preschool children.
This article has been cited by other articles:
![]() |
H. ZHOU, R. OHTSUKA, Y. HE, L. YUAN, T. YAMAUCHI, and A. C. SLEIGH IMPACT OF PARASITIC INFECTIONS AND DIETARY INTAKE ON CHILD GROWTH IN THE SCHISTOSOMIASIS-ENDEMIC DONGTING LAKE REGION, CHINA Am J Trop Med Hyg, May 1, 2005; 72(5): 534 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Stoltzfus, H. M. Chway, A. Montresor, J. M. Tielsch, J. K. Jape, M. Albonico, and L. Savioli Low Dose Daily Iron Supplementation Improves Iron Status and Appetite but Not Anemia, whereas Quarterly Anthelminthic Treatment Improves Growth, Appetite and Anemia in Zanzibari Preschool Children J. Nutr., February 1, 2004; 134(2): 348 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
Palmar Pallor as an Indicator for Anthelminthic Treatment Among Ill Children Aged 2-4 Years--Western Kenya, 1998 Arch Dermatol, August 1, 2001; 137(8): 1118 - 1119. [Full Text] [PDF] |
||||
![]() |
T. B. Gardner and D. R. Hill Treatment of Giardiasis Clin. Microbiol. Rev., January 1, 2001; 14(1): 114 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
Palmar Pallor as an Indicator for Anthelminthic Treatment Among Ill Children Aged 2-4 Years--Western Kenya, 1998 Arch Dermatol, August 1, 2000; 136(8): 1069 - 1070. [Full Text] [PDF] |
||||
![]() |
R. Dickson, S. Awasthi, P. Williamson, C. Demellweek, and P. Garner Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials BMJ, June 24, 2000; 320(7251): 1697 - 1701. [Abstract] [Full Text] |
||||
![]() |
Palmar Pallor as an Indicator for Anthelminthic Treatment Among Ill Children Aged 2-4 Years--Western Kenya, 1998 JAMA, June 14, 2000; 283(22): 2925 - 2927. [Full Text] [PDF] |
||||
![]() |
P. G. Lunn, H. O. Erinoso, C. A. Northrop-Clewes, and S. A. Boyce Giardia intestinalis Is Unlikely To Be a Major Cause of the Poor Growth of Rural Gambian Infants J. Nutr., April 1, 1999; 129(4): 872 - 877. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |